J. Almenara

Jorge A. Almenara, O. Ogunwobi, C. Dumur, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Synergistic induction of apoptosis in human myeloid leukemia cells by phorbol 12-myristate 13-acetate and flavopiridol proceeds via activation of both the intrinsic and tumor necrosis factor-mediated extrinsic cell death pathways.

P. Dent, S. Grant, L. Cartee, 2002, Molecular pharmacology.

Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol.

Jorge A. Almenara, S. Grant, R. Rosato, 2004, Molecular pharmacology.

Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14

Jorge A. Almenara, D. Gewirtz, Xu Di, 2013, Cancer Chemotherapy and Pharmacology.

The Sensitivity and Specificity of Touch Preparation for Rapid Diagnosis of Invasive Fungal Sinusitis: A Pilot Study

C. Powers, J. Yelverton, J. Almenara, 2019, Ear, nose, & throat journal.

The Sensitivity and Specificity of Touch Preparation for Rapid Diagnosis of Invasive Fungal Sinusitis: A Pilot Study

C. Powers, J. Yelverton, J. Almenara, 2018, Ear, nose, & throat journal.

Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy

J. Almenara, A. Sirica, Zichen Zhang, 2010, Hepatology.

The utility of ETV1, ETV4 and ETV5 RNA in‐situ hybridization in the diagnosis of CIC–DUX sarcomas

Dafydd G. Thomas, N. Palanisamy, B. Betz, 2017, Histopathology.

Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.

D. Conrad, P. Dent, S. Grant, 2003, Cancer research.

The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.

Jorge A. Almenara, S. Grant, R. Rosato, 2003, Cancer research.

The Histone Deacetylase Inhibitor MS-275 Promotes Differentiation or Apoptosis in Human Leukemia Cells through a Process Regulated by Generation of Reactive Oxygen Species and Induction of p 21 CIP 1 / WAF 1 1

S. Grant, R. Rosato, J. Almenara, 2003 .

A new death domain associated with gestational trophoblastic diseases induces apoptosis in distinct cell types.

C. Dumur, N. Koritschoner, A. Flury, 2001, International journal of oncology.

Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells.

Jorge A. Almenara, S. Grant, R. Rosato, 2003, Molecular cancer therapeutics.

NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263

Jorge A. Almenara, U. McDermott, M. Garnett, 2018, Clinical Cancer Research.

ntrahepatic Cholangiocarcinoma Progression: Prognostic Factors and asic Mechanisms

C. Dumur, J. Almenara, Jennifer L Dewitt, 2022 .

The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide.

P. Atadja, S. Payne, S. Spiegel, 2006, Molecular pharmacology.

Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells

P. Atadja, P. Dent, S. Grant, 2005, Molecular Cancer Therapeutics.

Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process

Jorge A. Almenara, E. Sausville, P. Dent, 2004, Oncogene.

RETRACTION: Flavopiridol and Histone Deacetylase Inhibitors Promote Mitochondrial Injury and Cell Death in Human Leukemia Cells That Overexpress Bcl-2

Jorge A. Almenara, S. Grant, G. Dasmahapatra, 2006, Molecular Pharmacology.

The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.

Jorge A. Almenara, S. Grant, R. Rosato, 2007, Cancer research.

An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients

Jorge A. Almenara, H. Cathro, S. V. Bontha, 2021, International journal of molecular sciences.

Digital Micrographs in Pathology

Roger S. Riley, Jorge A. Almenara, Christine E. Fuller, 2020 .

GATA3 is a reliable marker for neuroblastoma in limited samples, including FNA Cell Blocks, core biopsies, and touch imprints

Steven C. Smith, C. Powers, J. Almenara, 2017, Cancer cytopathology.

Analytical Validation and Clinical Utilization of the Oncomine Comprehensive Assay Plus Panel for Comprehensive Genomic Profiling in Solid Tumors

D. Pradhan, C. Dumur, J. Almenara, 2023, Journal of Molecular Pathology.

Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing

Andrea Ferreira-Gonzalez, Catherine I. Dumur, Jorge A. Almenara, 2015, Diagnostic Pathology.

A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.

Barbara S. Paugh, S. Milstien, S. Spiegel, 2008, Blood.

Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells.

P. Dent, S. Grant, Yun Dai, 2008, Blood.